Research and Clinical Trials

Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.

The publication aims to raise awareness of the toll cancer exacts on racial and ethnic minorities and other diverse and medically underserved populations in the United States while highlighting recent progress in reducing cancer disparities.

Mayo Clinic researchers are studying the cost-effectiveness of genomic research to detect certain diseases earlier, including breast, ovarian and colorectal cancer.

Alejandro Mirazo participated in a DNA research sequencing study to contribute diversity to medical research. It may have saved his life.

In this Mayo Clinic Q&A podcast video, Dr. Gerardo Colon-Otero and clinical trial participant Sonya Goins discuss equity in research and clinical trials.

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reports Mayo-led research team.

Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.

Clinical trials help physician-scientists improve cancer treatment, and can provide experimental, cutting-edge treatment options.

Researchers validated a diagnostic test for melanoma that combines genetic information from a skin biopsy with other characteristics to show whether patients are at risk of their cancer spreading.

New research finds that patients with ASXL1-mutant chronic myelomonocytic leukemia have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster.